David M. Brown

Active 1973–2025

Also published as
DAVID M. BROWN · David M Brown
167
Papers
47,846
Citations
99
h-index
158
i10-index

Citations

Citations per year for David M. Brown1952: 1 citations1965: 4 citations1972: 1 citations1974: 1 citations1975: 3 citations1976: 5 citations1977: 1 citations1978: 7 citations1979: 7 citations1980: 5 citations1981: 35 citations1982: 24 citations1983: 32 citations1984: 30 citations1985: 30 citations1986: 41 citations1987: 22 citations1988: 37 citations1989: 40 citations1990: 23 citations1991: 35 citations1992: 50 citations1993: 37 citations1994: 38 citations1995: 35 citations1996: 35 citations1997: 17 citations1998: 30 citations1999: 64 citations2000: 65 citations2001: 57 citations2002: 58 citations2003: 107 citations2004: 88 citations2005: 137 citations2006: 170 citations2007: 260 citations2008: 274 citations2009: 287 citations2010: 303 citations2011: 301 citations2012: 367 citations2013: 396 citations2014: 393 citations2015: 399 citations2016: 369 citations2017: 329 citations2018: 264 citations2019: 1,146 citations2020: 1,123 citations2021: 1,139 citations2022: 822 citations2023: 827 citations2024: 1,415 citations2025: 676 citations2026: 27 citations1953–1964: no citations, so these years are not shown1966–1971: no citations, so these years are not shown1973: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,055 citing papers, 28.2% of this breakdownUnited Kingdom: 964 citing papers, 8.9% of this breakdownChina: 645 citing papers, 6% of this breakdownGermany: 595 citing papers, 5.5% of this breakdownItaly: 521 citing papers, 4.8% of this breakdownJapan: 446 citing papers, 4.1% of this breakdownSwitzerland: 403 citing papers, 3.7% of this breakdownAustralia: 389 citing papers, 3.6% of this breakdownFrance: 344 citing papers, 3.2% of this breakdownCanada: 249 citing papers, 2.3% of this breakdownIndia: 232 citing papers, 2.1% of this breakdownNetherlands: 227 citing papers, 2.1% of this breakdown
0%28.2%Other 25.5%

Fields

  • Medicine66.8%
  • Biochemistry, Genetics and Molecular Biology12%
  • Environmental Science6.9%
  • Materials Science6.3%
  • Immunology and Microbiology2.8%
  • Neuroscience1.3%
  • Other3.9%

Topics

  • Retinal Diseases and Treatments16.7%
  • Retinal Imaging and Analysis6.7%
  • Ocular Diseases and Behçet’s Syndrome5.1%
  • Ophthalmology and Visual Impairment Studies4%
  • Retinal and Optic Conditions3.3%
  • Retinal Development and Disorders2.7%
  • Other61.5%

Coauthors

All papers

Open in search
  1. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luis Arias, Jennifer Arnold, Riaz Asaria, Sergei Astakhov, Yury Astakhov, Carl C. Awh, Chandra Balaratnasingam, Sanjiv Banerjee, Caroline Baumal, Matthias Becker, Rubens Belfort, Galina Bratko, William Jr. Z Bridges, Jamin Brown, David M. Brown, Maria Budzinskaya, Sylvia Buffet, Stuart Burgess, Iksoo Byon, Carlo Cagini, Jorge Calzada, Stone Cameron, Peter Campochiaro, John Carlson, Angela Carneiro, Clement Chan, Emmanuel Chang, Andrew Chang, Daniel Chao, Nauman Chaudhry, Caroline Chee, Andrew Cheek, Shih-Jen Chen, San-Ni Chen, Gemmy Cheung, Saradha Chexal, Mark Chittum, David Chow, Abosede Cole, Brian Connolly, Pierre Loic Cornut, Stephen Couvillion, Carl Danzig, Vesselin Daskalov, Amr Dessouki, Francois Devin, Michael Dollin, Rosa Dolz, Louise Downey, Richard Dreyer, Pravin Dugel, David Eichenbaum, Bora Eldem, Robert Engstrom, Joan Josep Escobar, Nicole Eter, David W. Faber, Naomi Falk, Leonard Feiner, Alvaro Fernandez Vega, Philip Ferrone, Marta Figueroa, Howard Fine, Mitchell Fineman, Gregory M. Fox, Catherine Francais, Pablo Franco, Samantha Fraser-Bell, Nicholas Fung, Federico Furno Sola and 218 more - The Lancet 2022 cited by 686

  2. Ranibizumab for Neovascular Age-Related Macular Degeneration

    Authors: , , , , , , - New England Journal of Medicine 2006 cited by 5,866

  3. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander M. Eaton, Alexander Rubowitz, Alice T. Lyon, Allen Chiang, Allen C. Ho, Allen Hu, Amir Guerami, Amr Dessouki, André Corrêa Maia de Carvalho, Andrés Emanuelli, Andrew Chang, Andrew N. Antoszyk, A Francone, Anita Prasad, Armin Wolf, Arshad M. Khanani, Ashkan M. Abbey, Asma Moulana, Barbara Wihelm, Bartosz L. Sikorski, Baruch D. Kuppermann, Benjamin Wolff, Brian Jewart, K. Brian, Brian T. Chan-Kai, Calvin E. Mein, Carel B. Hoyng, Carl C. Awh, Carl Regillio, Carlos Zeolite, Caroline R. Baumal, Catherine Creuzot‐Garcher, Catherine Français Maury, Charles C. Wykoff, Charles K Newell, Chirag Jhaveri, Chris P. Lohmann, Christiana Dinah, Colin Ma, Courtney Crawford, D Wilkin Parke, Daniel Lavinsky, Daniel B. Roth, Dante J. Pieramici, Darius M. Moshfeghi, Darrin Levin, David A. Saperstein, David M. Brown, David Gaucher, David R. Lally, David Liao, David Warren Brown, Debra A. Goldstein, Dennis M. Marcus, Derek G. Chan, Dilsher S. Dhoot, Domingo Tacite, Dominik Zalewski, Edgar M. Espana, Eleonora M. Lad, Eric H. Souied, Eric Suan, Eva Eting, Federico Furno Sola, F. De Bats, Francesco Bandello, Francisco Gómez‐Ulla, François Devin, Frank G. Holz, Fred K. Chen and 163 more - The Lancet 2023 cited by 443

  4. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

    Authors: , , , , , , , , , , , , , , , , , , , - Ophthalmology 2012 cited by 2,470

  5. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Virgil Alfaro, Daniel Aliseda, Arghavan Almony, Pedro Amat, Payam Amini, Andrew Antoszyk, Luis Arias, Riaz Asaria, Marcos Avila, Carl C Awh, Joaquin Bafalluy, Carl Baker, Francesco Bandello, Mark Barakat, Karen Barraza, Gyorgy Bator, Caroline Baumal, Rubens Belfort Jr, Chris Bergstrom, George Bertolucci, Thomas Bochow, Matthias Bolz, Emilia Borcz, Arnaldo Bordon, David Boyer, Galina Bratko, Michael Brent, Jamin Brown, David M Brown, Maria Budzinskaya, Sylvia Buffet, Stuart Burgess, Ben Burton, Miguel Busquets, Francisco Cabrera, Carlo Cagini, Jorge Calzada, Peter Campochiaro, John Carlson, Alessandro Castellarin, Carlos Cava, Voraporn Chaikitmongkol, Clement Chan, Emmanuel Chang, Jonathan Chang, Andrew Chang, Steve Charles, Nauman Chaudhry, Caroline Chee, Judy Chen, Fred Chen, Shih-Jen Chen, Richard Cheong-Leen, Allen Chiang, Mark Chittum, David Chow, Brian Connolly, Pierre Loic Cornut, Karl Csaky, Carl Danzig, Arup Das, Vesselin Daskalov, Carmen Desco, Amr Dessouki, John Dickinson, Brian Do, Michael Dollin, Pravin Dugel, Jaroslava Dusova, David Eichenbaum and 296 more - The Lancet 2022 cited by 435

  6. HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

    Authors: , , , , , , , , , - Ophthalmology 2019 cited by 911

  7. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration

    Authors: , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2019 cited by 512

  8. Vaccination induces HIV broadly neutralizing antibody precursors in humans

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David M. Brown, David R. Ambrozak, Troy Sincomb, Xiaozhen Hu, Ryan Tingle, Erik Georgeson, Saman Eskandarzadeh, Nushin Alavi, Danny Lu, Tina-Marie Mullen, Michael Kubitz, Bettina Gröschel, Janine Maenza, Orpheus Kolokythas, Nadia J. Khati, Jeffrey M. Bethony, Shane Crotty, Mario Roederer, Gunilla B. Karlsson Hedestam, Georgia D. Tomaras, David C. Montefiori, David Diemert, Richard A. Koup, Dagna Laufer, M. Juliana McElrath, Adrian B. McDermott, William R. Schief - Science 2022 cited by 272

  9. Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

    Authors: , , , , , , , - New England Journal of Medicine 2006 cited by 3,503

  10. Ranibizumab for Diabetic Macular Edema

    Authors: , , , , , , , , , , , - Ophthalmology 2012 cited by 1,600

  11. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Edwards, Carl W. Baker, Michael Novák, Ricky D. Isernhagen, Todd E. Schneiderman, Lawrence S. Halperin, Michael H. Lee, David S. Boyer, Philip J. Rosenfeld, Pamela Rath, Marc H. Levy, Robert H. Rosa, John C. Hoskins, Clement K. Chan, David M. Brown, Craig M. Greven, J Michael Jumper, Linda J. Margulies, William N. Rosenthal, Richard B. Rosen, Glenn Stoller, Fadi El Baba, W. Copley McLean, Ronald Kingsley, Alice T. Lyon, Jeffrey S. Heier, Anne E. Fung, Ingrid U. Scott, John A. Wells, Michael J. Banach, Paul M. Beer, James C. Folk, Joseph I. Maguire, Srinivas R. Sadda, Richard A. Garfinkel, Judy E. Kim, Paul Berstein, Michael Rauser, Richard A. Lewis, Barron C. Fishburne, Suber Huang, Nelson R. Sabates, Nicola Kim, Robert N. Frank, Brian C. Joondeph, Odette M. Houghton, Dean P. Hainsworth, Edward Chaum, Robert H. Millay, Raymond Iezzi, Rajendra S. Apte, Ron A. Adelman, Anita Agrawal, Neelakshi Bhagat, Lawrence Ulanski, Steven D. Schwartz, Cynthia Owsley, Alan Letson, Yu-Guang He, Cynthia A. Toth, Lawrence S. Morse, Michael J. Cooney, Sandeep Grover, Henry Ferreyra, Alexander J. Brucker, David DiLoreto, Aaron Weinberg - JAMA Ophthalmology 2022 cited by 172

  12. Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration

    Authors: , , , , , , , - Ophthalmology 2013 cited by 502

  13. Faricimab Treat-and-Extend for Diabetic Macular Edema

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Suhail Alam, Arturo Alezzandrini, Virgil Alfaro, Daniel Aliseda, Arghavan Almony, Pedro Amat, Payam Amini, Andrew N. Antoszyk, Luís Arias, Riaz Asaria, Marcos Pereira de Ávila, Carl C. Awh, Joaquín Bafalluy, Carl W. Baker, Francesco Bandello, Mark Barakat, Karen Barraza, György Bátor, Caroline R. Baumal, Rubens Belfort, Chris Bergstrom, George Bertolucci, Thomas W. Bochow, Matthias Bolz, Emilia Borcz, Arnaldo Furman Bordon, David S. Boyer, Galina Bratko, Michael H. Brent, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ben Burton, Miguel Busquets, Francisco Cabrera, Carlo Cagini, Jorge I. Calzada, Peter A. Campochiaro, John S. Carlson, Alessandro Castellarin, Carlos Eduardo Cava, Voraporn Chaikitmongkol, Clement Chan, Emmanuel Chang, Jonathan S. Chang, Andrew Chang, Steve Charles, Nauman Chaudhry, Caroline Chee, Judy Chen, Fred K. Chen, Shih‐Jen Chen, Richard Cheong-Leen, Allen Chiang, Mark Chittum, David R. Chow, B. Connolly, Pierre Loïc Cornut, Karl G. Csaky, Carl J. Danzig, Arup Das, Vesselin Daskalov, Carmen Desco, Amr Dessouki, John D. Dickinson, Brian Do, Michael Dollin, Pravin U. Dugel and 297 more - Ophthalmology 2023 cited by 138

  14. Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

    Authors: , , , , , - Ophthalmology 2008 cited by 1,316

  15. Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders

    Authors: , , , , , , , , , , , , , - Progress in Retinal and Eye Research 2021 cited by 360

  16. TENAYA and LUCERNE

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew N. Antoszyk, Etelka Aradi, Luís Arias, Jennifer Arnold, Riaz Asaria, Sergei Astakhov, Yury S. Astakhov, Carl C. Awh, Chandra Balaratnasingam, Sanjiv Banerjee, Caroline R. Baumal, Matthias Becker, Rubens Belfort, Galina Bratko, William Bridges, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ik Soo Byon, Carlo Cagini, Jorge I. Calzada, Stone Cameron, Peter A. Campochiaro, John S. Carlson, Ângela Carneiro, Clement Chan, Emmanuel Chang, Andrew Chang, Daniel L. Chao, Nauman Chaudhry, Caroline Chee, Andrew Cheek, Shih‐Jen Chen, San‐Ni Chen, Gemmy Cheung, Saradha Chexal, Mark Chittum, David R. Chow, Abosede Cole, B. Connolly, Pierre Loïc Cornut, Stephen Couvillion, Carl J. Danzig, Vesselin Daskalov, Amr Dessouki, François Devin, Michael Dollin, Rosa Dolz, Louise Downey, Richard F. Dreyer, Pravin U. Dugel, David Eichenbaum, Bora Eldem, Robert E. Engstrom, Joan Josep Escobar, Nicole Eter, David Faber, Naomi S. Falk, Leonard Feiner, Alvaro Fernandez Vega, Philip J. Ferrone, Marta S. Figueroa, Howard F. Fine, Mitchell S. Fineman, Gregory M. Fox, Catherine Français, Pablo Moreno Franco, Samantha Fraser‐Bell and 217 more - Ophthalmology 2024 cited by 179

  17. Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2013 cited by 811

  18. Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study

    Authors: , , , , , , , , , , , - The Lancet 2024 cited by 119

  19. Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William Bridges, James W. Dooner, Wayne Solley, Andrés Emanuelli, Ronald Teed, Scott M. Friedman, Nader Moinfar, Ghassan Ghorayeb, Shelly Lee, Daniel M. Berinstein, Mitchell J. Goff, Harvey Reiser, Amir Guerami, Emily D. Ashmore, Curtis Hagedorn, Jose A. Martinez, Paul Hahn, Juner Colina-Biscotto, Vrinda Hershberger, Brian C. Joondeph, Erik Kruger, J. Shepard Bryan, Michael Lee, Mark L. Chiu, C. Nathaniel Roybal, Frank Wyant, James K. Luu, Matthew Byun, James D. Palmer, Mark R. Wieland, Joel Pearlman, Evan Berger, John D. Pitcher, Rajiv Rathod, Omar S. Punjabi, Leonard Feiner, Hema L. Ramkumar, Steven Lin, Rahul Reddy, Richard F. Dreyer, Nathan Steinle, Veeral Sheth, David Faber, Cameron Stone, Robert E. Engstrom, Robert S. Wirthlin, Mahmood El-Gasim, Robert Parnes - JAMA Ophthalmology 2023 cited by 103

  20. Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fareed Ali, Payam Amini, Andres Emanuelli Anzalotta, György Bátor, Ivan R. Batlle, Adam Berger, Ramanath Bhandari, William Bridges, Christian Brinkmann, Jamin S. Brown, Stuart C Burgess, Jorge I. Calzada, Antonio Capone, Dana Cervena, Steven Charles, Nauman Chaudhry, David R. Chow, W. Lloyd Clark, Paul Conrad, Matthew A. Cunningham, Hajir Dadgostar, Amr Dessouki, Dana Madison Deupree, Christopher A. Devine, David Eichenbaum, Jan Ernest, Nicolas Feltgen, M. J. Fenberg, Philip J. Ferrone, R. E. P. Frenkel, Scott M. Friedman, Julie Gasperini, Adam T. Gerstenblith, Ghassan Ghorayeb, Michel Giunta, Mitchell J. Goff, Liliya Golas, Joseph M. Googe, Jordana Fein, Curtis Hagedorn, Akira Hagiwara, Paul Hahn, Richard Hairston, Jason M. Handza, Vivienne Hau, Ken Hayashi, Jeffrey S. Heier, Vrinda Hershberger, Patrick Higgins, Yoshio Hirano, Shigeru Honda, Yasuko Ikegami, Yuichiro Ishida, Isao Ishikawa, Kiyoshi Ishii, Eric Jablon, Atul Jain, Yuichi Kaji, Kapil Kapoor, Ágnes Kerényi, Kazuhiro Kimura, Genichiro Kishino, Katalin Kiss, Takashi Kitaoka, James M. Klancnik, Namie Kobayashi, Jiro Kogo, Vladimír Korda, Erik Kruger, Sentaro Kusuhara and 55 more - The Lancet 2024 cited by 113

  21. KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema

    Authors: , , , , , , , , , , , , , , , , , , - American Journal of Ophthalmology 2022 cited by 168

  22. Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials

    Authors: , , , , , , , , , , , , - Ophthalmology 2013 cited by 821

  23. Intravitreal Aflibercept for Diabetic Macular Edema

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2014 cited by 807

  24. Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy

    Authors: , , , , , , , , , , , , , , - JAMA Ophthalmology 2021 cited by 148